Microbot Medical to expand veteran access to robotic surgery with LIBERTY

Microbot Medical's LIBERTY system is a single-use, remotely operated endovascular robotic system.

LIBERTY is a single-use, remotely operated endovascular robotic system. | Source: Microbot Medical

Robotics can help improve the quality of care for U.S. military veterans. Microbot Medical Inc. this week said it is working with Lovell Government Services Inc. to serve federal healthcare systems.

This includes those run by the Veterans Health Administration (VHA), a division of the U.S. Department of Veteran Affairs, the Military Health System (MHS), which is run by the U.S. Department of War, and the U.S. Indian Health Service (IHS).

Lovell Government Services will become Microbot’s service-disabled veteran-owned small business (SDVOSB) vendor to serve these customers through federal contracting systems.

“We are proud to partner with Microbot Medical to help expand access to innovative healthcare technologies for our nation’s veterans, active-duty service members, and Native American communities,” stated Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services.

“The LIBERTY Endovascular Robotic System represents a significant advancement in minimally invasive vascular care, and we look forward to supporting its availability across federal healthcare systems,” he added. “Our mission is to connect government providers with best-in-class solutions that improve patient outcomes while simplifying the procurement process, and this partnership reflects that commitment.”

Microbot designs compact surgical system

Hingham, Mass.-based Microbot Medical offers LIBERTY, an endovascular robotic system for interventional physicians and hospitals seeking to improve procedural precision, safety, and efficiency.

Unlike traditional manual techniques, the surgical robot offers a single-use, compact design that enables controlled remote operation, claimed the company. LIBERTY can work in neurovascular, cardiovascular, and peripheral vascular procedures. Microbot added that it could lower procedure costs and improve the overall quality of care.

In May, the Israeli Ministry of Health’s AMAR Division gave LIBERTY its first international regulatory approval, as Microbot transitioned to limited to full market release.

Earlier this month, Microbot said that an academic center in North Carolina was the first to adopt LIBERTY in the Southeast and Mid-Atlantic region. Last week, it announced that one of the largest healthcare systems in Michigan had adopted its technology.

Working with Lovell could make LIBERTY more accessible

Pensacola, Fla.-based Lovell Government Services has been a SDVOSB vendor since 2013. It has a track record of introducing suppliers to the government market. Microbot Medical’s LIBERTY System will be added to Lovell’s Federal Supply Schedule (FSS) contract. The companies expect activation during the third quarter of 2026.

The LIBERTY System will also be accessible through additional federal procurement platforms. This includes GSA Advantage, the Defense Logistics Agency’s Electronic Catalog (ECAT), and the Department of War’s Distribution and Pricing Agreement (DAPA).

“As someone who has represented the U.S. in two Olympics, it is an honor to join with Lovell to ensure those who have served in the military along with their physicians have access to advanced medical technologies that address their needs,” said Christina Bailey, the vice president of U.S. Sales at Microbot.

“Building on our continued commercial momentum, we believe this partnership will expand awareness and adoption of our technology across Lovell’s extensive network,” she said. “Contracted access is a key component of our commercial strategy, providing customers with a streamlined procurement pathway and confidence in product availability. As interest in our technology continues to grow, we believe now is the right time to start this relationship and its potential for broader adoption.”

Microbot said it expects that listing products with Lovell will streamline the sales process while helping government agencies meet their SDVOSB procurement goals. The company serves thousands of government care sites nationwide, including 170 medical centers and numerous outpatient clinics. It averages over 200 peripheral endovascular cases annually, per site.